TGFB1 and ovarian carcinoma: Specifically in ovarian cancer, one study by Hong et al. [33] discovered that downregulation of liver kinase b1 (LKB1) stimulated TGF-β expression and EMT, which led to the resistance of chemotherapy of ovarian cancer cells to chemotherapy.